Antimicrobial susceptibility of anaerobic bacteria in Belgium as determined by E-test methodology

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 28, Issue 3, 2009, Pages 261-267

  Glupczynski, Y ^a,b   Berhin, C ^a   Nizet, H ^a  

^a UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE; CEFOXITIN; CLINDAMYCIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; BELGIUM; CONTROLLED STUDY; EPSILOMETER TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BELGIUM; BETA-LACTAMASES; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 61349184462     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-008-0624-1     Document Type: Article

References (18)

1. AO Tzianabos DL Kasper 2005
2. DR Snydman NV Jacobus LA McDermott 2007 National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004 Antimicrob Agents Chemother 51 1649 1655
3. M Hedberg CE Nord ESCMID Study Group on Antimicrobial Resistance in Anaerobic Bacteria 2003 Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe Clin Microbiol Infect 9 475 488
4. J Papaparaskevas A Pantazatou A Katsandri 2005 Multicentre survey of the in-vitro activity of seven antimicrobial agents, including ertapenem, against recently isolated Gram-negative anaerobic bacteria in Greece Clin Microbiol Infect 11 820 824
5. SA Roberts KP Shore SD Paviour D Holland AJ Morris 2006 Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999-2003 J Antimicrob Chemother 57 992 998
6. JH Salonen E Eerola O Meurman 1998 Clinical significance and outcome of anaerobic bacteremia Clin Infect Dis 26 1413 1417
7. MH Nguyen VL Yu AJ Morris 2000 Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial Clin Infect Dis 30 870 876
8. Jousimies-Somer HR, Summanen P, Citron DM, Baron EJ, Wexler HM, Finegold SM (eds) (2002) Wadsworth anaerobic bacteriology manual, 6th edn. Star, Belmont, CA
9. DM Citron MI Ostovari A Karlsson EJC Goldstein 1991 Evaluation of the E-test for susceptibility testing of anaerobic bacteria J Clin Microbiol 29 2197 2203
10. JE Rosenblatt DR Gustafson 1995 Evaluation of the Etest for the susceptibility testing of anaerobic bacteria Diagn Microbiol Infect Dis 22 279 284
11. DM Citron DW Hecht 2007
12. Clinical and Laboratory Standards Institute (2007) Methods for antimicrobial susceptibility testing of anaerobic bacteria, 7th edn. Approved Standard, Document M11-A7. CLSI, Wayne, PA
13. A Bolmström A Karlsson A Engelhardt 2007 Validation and reproducibility assessment of tigecycline MIC determinations by Etest J Clin Microbiol 45 2474 2479
14. I Wybo D Piérard I Verschraegen 2007 Third Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria J Antimicrob Chemother 59 132 139
15. J Papaparaskevas A Pantazatou A Katsandri 2008 Moxifloxacin resistance is prevalent among Bacteroides and Prevotella species in Greece J Antimicrob Chemother 62 137 141
16. J Oten-Iglesias JI Alos JL Gomez-Garces 2002 Increase in resistance to new fluoroquinolones from 1998 to 2001 in the Bacteroides fragilis group J Antimicrob Chemother 50 1055 1057
17. H Goossens M Ferech R Vander Stichele ESAC Project Group 2005 Outpatient antibiotic use in Europe and association with resistance: a cross-national database study Lancet 365 579 587
18. C Betriu E Culebras M Gomez 2005 In vitro activity of tigecycline against Bacteroides species J Antimicrob Chemother 56 349 352